These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1483278

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Attempt with oral immunobiotherapy (broncho-vaxom) and immunochemotherapy (broncho-vaxom + neomycin) for the elimination of bacteria in symptom-free "other Salmonella" carriers.
    Münnich D, Dalmi L.
    Ther Hung; 1989; 37(4):209-15. PubMed ID: 2631289
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Value of Imocur in the prevention of recurrent infections in children under six years of age. Results of a multicenter, placebo-controlled trial].
    Paupe J.
    Ann Pediatr (Paris); 1990 Sep; 37(7):475-9. PubMed ID: 2256645
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The role of OM-85 BV (Broncho-Vaxom) in preventing recurrent acute tonsillitis in children.
    Bitar MA, Saade R.
    Int J Pediatr Otorhinolaryngol; 2013 May; 77(5):670-3. PubMed ID: 23380631
    [Abstract] [Full Text] [Related]

  • 28. Use of Broncho-Vaxom in private practice: phase IV trial in 587 children.
    Berber AC, Del-Rio-Navarro BE.
    Clin Ther; 1996 May; 18(6):1068-79. PubMed ID: 9001824
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Broncho-Vaxom in the treatment of bronchial asthma in children].
    Lewandowska J, Piltz D, Willak B.
    Pol Tyg Lek; 1996 May; 42(3-4):93-5. PubMed ID: 3601766
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children].
    Gómez Barreto D, De la Torre C, Alvarez A, Faure A, Berber A.
    Allergol Immunopathol (Madr); 1998 May; 26(1):17-22. PubMed ID: 9585823
    [Abstract] [Full Text] [Related]

  • 38. Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study.
    Esposito S, Bianchini S, Polinori I, Principi N.
    Int J Environ Res Public Health; 2019 Mar 25; 16(6):. PubMed ID: 30934539
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of thymostimulin and study of lymphocyte-dependent antibacterial activity in children with recurrent respiratory infections.
    De Mattia D, Decandia P, Ferrante P, Pace D, Martire B, Ciccarelli M, Caradonna L, Ribaud MR, Jirillo E, Schettini F.
    Immunopharmacol Immunotoxicol; 1993 Aug 25; 15(4):447-59. PubMed ID: 8227971
    [Abstract] [Full Text] [Related]

  • 40. [Prevention and treatment of upper respiratory tract infections with IRS-19 and polydex with phenylephrine].
    Luchikhin LA, Beliakova LV, Gurov AV.
    Vestn Otorinolaringol; 2000 Aug 25; (4):54-7. PubMed ID: 11011582
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.